Scynexis Inc
USUSDScynexis Inc (US:SCYX) — Biotechnology: Pharmaceutical Preparations. Antal børser, hvor selskabets aktier handles: 2. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.
Om Virksomheden
- Websted
- scynexis.com
- Sektor
- Health Care · Biotechnology: Pharmaceutical Preparations
- Hovedkontor
- JERSEY CITY, United States
- Administrerende Direktør
- David Gonzalez Angulo
- Ansatte
- 18
- Udestående Aktier
- 9.95 mio. pr. 2026-08-01
- Free Float
- 7.35 mio.
- Markedsværdi
- 40.59 mio. USD
- Insidere
- 2.05%
- Institutionelle Investorer
- 62.11%
- Branche (SIC)
- Pharmaceutical Preparations
- FCF
- 18.4 mio. USD
- Gæld
- 34.6 mio. USD0.4 år FCF
- Indtjening og FCF — for de 12 måneder frem til 30.06.2026 (virksomhedens seneste rapport).
Beskrivelse
SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Største Ejere
| Ejer | Andel | Aktier | Rapportdato |
|---|---|---|---|
| ANGULO GONZALEZ DAVID (C… | ≈13.63% | 1.36 mio. | 2026-04-01 |
| Great Point Partners LLC | 9.49% | 944 292 | 2026-06-30 |
| Squadron Capital Managem… | 7.61% | 756 884 | 2026-06-30 |
| SUKENICK SCOTT (Officer) | ≈5.77% | 574 539 | 2026-01-29 |
| Propel Bio Management, L… | 5.46% | 543 478 | 2026-06-30 |
| Adage Capital Partners G… | 5.46% | 543 478 | 2026-06-30 |
| MACLEOD IVOR (Chief Fina… | ≈4% | 398 529 | 2026-01-29 |
| Woodline Partners LP | 3.89% | 387 520 | 2026-06-30 |
| Vanguard Capital Managem… | 2.98% | 296 747 | 2026-06-30 |
| Avidity Partners Managem… | 2.62% | 260 206 | 2026-06-30 |
| Kingdon Capital Manageme… | 2.49% | 247 811 | 2026-06-30 |
| Millennium Management Ll… | 1.82% | 180 788 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.53% | 152 542 | 2026-06-30 |
| Heights Capital Manageme… | 1.51% | 150 551 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.29% | 128 195 | 2026-06-30 |
| GILMAN STEVEN C (Directo… | ≈0.7% | 70 000 | 2025-06-26 |
| Fidelity Concord Street… | 0.52% | 52 120 | 2026-07-31 |
| Fidelity Concord Street… | 0.16% | 15 761 | 2026-07-31 |
| EA Series Trust-EA Bridg… | 0.16% | 15 462 | 2026-06-30 |
| MACDONALD GUY (Director) | ≈0.13% | 12 625 | 2026-06-26 |
| TINMOUTH BRIAN PHILIPPE… | ≈0.12% | 12 125 | 2026-06-26 |
| ANIDO ARMANDO (Director) | ≈0.12% | 11 750 | 2026-06-26 |
| HANHAM ANN F (Director) | ≈0.12% | 11 577 | 2026-06-26 |
| HASTINGS DAVID C (Direct… | ≈0.12% | 11 522 | 2026-06-26 |
| Fidelity Concord Street… | 0.08% | 8 333 | 2026-07-31 |
| VANGUARD VALLEY FORGE FU… | 0.06% | 5 910 | 2026-06-30 |
| BURKE STEVEN KEITH (Dire… | ≈0.06% | 5 750 | 2026-09-18 |
| Fidelity Concord Street… | 0.05% | 5 257 | 2026-07-31 |
| Dimensional ETF Trust-Di… | 0.05% | 5 189 | 2026-07-31 |
| DFA INVESTMENT DIMENSION… | 0.05% | 4 831 | 2026-07-31 |
